Invivyd, Inc.
USD0.91
-0.03 (-3.23%)
CEO
William E. Duke Jr.
IPO Date
2021-08-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.95
Prev. Close
$0.94
Day Low
$0.91
Day High
$0.95
52W Low
$0.48
52W High
$3.07
Market Cap
$0.27B
Volume
0.46M
| 50,000 |
| $1.04 |
| 21 May 2026 | MCGUIRE TERRANCE | director | A-Award | Acquired | 50,000 | $1.04 |
| 21 May 2026 | Elia Marc | director, other: See Remarks | A-Award | Acquired | 50,000 | $1.04 |
| 21 May 2026 | BOLNO PAUL | director | A-Award | Acquired | 32,876 | $1.04 |
| 21 May 2026 | Berry Tamsin | director | A-Award | Acquired | 50,000 | $1.04 |
| 18 Feb 2026 | Allen Robert D. III | Chief Scientific Officer | M-Exempt | Acquired | 99,000 | $0.00 |
| 18 Feb 2026 | Allen Robert D. III | Chief Scientific Officer | S-Sale | Disposed | 18,189 | $1.54 |
| 18 Feb 2026 | Allen Robert D. III | Chief Scientific Officer | S-Sale | Disposed | 19,392 | $1.58 |
| 18 Feb 2026 | Allen Robert D. III | Chief Scientific Officer | M-Exempt | Disposed | 99,000 | $0.00 |